The three G-protein-coupled cannabinoid receptor subtypes currently recognized are central (CB1), peripheral (CB2), and GPR55. The majority of CB1 receptors are found at central and peripheral nerve terminals. CB2 receptors are mainly found in immune cells and non-neuronal tissues where they regulate cytokine release and cell migration. According to recent reports, the CNS may also express CB2 receptors. Non-CB1/CB2 receptors known as GPR55 show affinity for endogenous, botanical, and synthetic cannabinoids. Anandamide and 2-arachidonylglycerol are examples of endogenous ligands for cannabinoid receptors.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V105254 | (-)-11-Hydroxy-Δ8-tetrahydrocannabivarin | 1421594-84-4 | (-)-11-Hydroxy-Δ8-tetrahydrocannabinol ((-)-11-hydroxy-Δ8-THCV) is a synthetic cannabinoid. |
![]() |
V105410 | (-)-7-Nor-7-carboxy cannabidiol | 63958-77-0 | (-)-7-N-7-Carboxycannabidiol is a phytocannabinoid metabolite. |
![]() |
V106711 | (1H-Indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 895152-66-6 | (1H-Indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144 Impurity 3) is a cannabinoid precursor. |
![]() |
V71597 | (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide | 220556-74-1 | (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide (Compound 19) is an analog of the endocannabinoid receptor ligand Anandamide. |
![]() |
V71551 | (R)-Monlunabant ((R)-MRI-1891) | 2765579-76-6 | (R)-Monlunabant ((R)-MRI-1891) is a CB1 receptor modulator utilized in study/research of obesity and metabolic diseases. |
![]() |
V104942 | (±)-6',7'-Dihydroxy cannabichromene | 134840-96-3 | (±)-6',7'-Dihydroxycannabichromene is a phytocannabinoid metabolite. |
![]() |
V104941 | (±)-6',7'-Epoxy cannabichromene | 134840-95-2 | (±)-6',7'-Epoxycannabichromene is a phytocannabinoid metabolite. |
![]() |
V104940 | (±)-8'-Hydroxy cannabichromene | 132032-41-8 | 8'-Hydroxycannabichromene is a phytocannabinoid metabolite. |
![]() |
V104518 | (±)-9-Nor-9α-hydroxy Hexahydrocannabinol | 56469-26-2 | (±)-9-n-9α-Hydroxyhexahydrocannabinol is a cannabinoid-type compound with potent cannabinoid-like activity in dogs and mice. |
![]() |
V104519 | (±)-9-Nor-9β-hydroxy Hexahydrocannabinol | 56469-25-1 | (±)-9-Nor-9β-hydroxyhexahydrocannabinol is a cannabinoid analog. |
![]() |
V104947 | (±)-9α-Hydroxy hexahydrocannabinol | 16964-49-1 | (±)-9α-Hydroxyhexahydrocannabinol ((±)-9α-hydroxyHHC) is a phytocannabinoid analog. |
![]() |
V105268 | (±)-Cannabichromebutolic acid | 2691096-32-7 | (±)-Cannabismobutyric acid is a phytocannabinoid analog. |
![]() |
V102918 | (±)-Cannabichromeorcin | 55824-09-4 | (±)-Cannabinoids are a cannabinoid compound. |
![]() |
V105255 | (±)-CBCP | 55824-16-3 | (±)-CBCP ((±)-cannabidiol) is a phytocannabinoid analog. |
![]() |
V102786 | 1'-Naphthoyl-2-methylindole | 80749-33-3 | 1'-Naphthoyl-2-methylindole (Compound 88) is a cannabinoid mimetic and inhibitor of Win 55212-2, inhibiting the binding of [3H]Win 55212-2 to cannabinoid receptors by 34% at 3 μM. |
![]() |
V107656 | 1-(1-Methyl-1H-indol-3-yl)-2-(1-naphthalenyl)ethanone | 1638677-49-2 | 1-(1-Methyl-1H-indol-3-yl)-2-(1-naphthyl)ethanone is a structural analog of cannabinoids. |
![]() |
V104945 | 10(R)-Hydroxy-9(S)-hexahydrocannabinol | 60948-21-2 | 10(R)-Hydroxy-9(S)-hexahydrocannabinol is a phytocannabinoid analog. |
![]() |
V105241 | 10α-Hydroxy-Δ8-THC | 24902-23-6 | 10α-Hydroxy-Δ8-THC (10α-hydroxy-Δ8-tetrahydrocannabinol) is a phytocannabinoid. |
![]() |
V104572 | 11(Z),14(Z)-Eicosadienoic acid ethanolamide | 162758-92-1 | 11(Z),14(Z)-eicosadienoic acid ethanolamide (Compound 3) is the ethanolamide conjugated form of 11(Z),14(Z)-eicosadienoic acid. |
![]() |
V104520 | 11-Hydroxy-9(R)-hexahydrocannabinol | 64663-39-4 | 11-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid analog. |